En español
NIDA

Oklahoma Opioid Summary

Revised February 2018

Opioid-Related Overdose Deaths

In 2016, there were 444 opioid-related overdose deaths­­­ in Oklahoma—a rate of 11.6 deaths per 100,000 persons—compared to the national rate of 13.3 deaths per 100,000. Since 2012, heroin overdose deaths have more than doubled from 26 deaths to 53 deaths in 2016. However, prescription opioid overdose deaths have declined since 2014 from 424 to 322 deaths.

This graph shows the rate of opioid-related overdose deaths in Oklahoma compared to the United States from 1999-2016. In 2016, the opioid overdose death rate was 11.6 deaths per 100,000 persons in Oklahoma, versus 13.3 deaths per 100,000 persons in the United States.

Opioid Pain Reliever Prescriptions

In 2015, Oklahoma providers wrote 101.7 opioid prescriptions per 100 persons (3.97 million prescriptions). In the same year, the average U.S. rate was 70 opioid prescriptions per 100 persons (IMS Health, 2016).

This graph shows the number of opioid-related overdose deaths in Oklahoma from 1999-2016. In 2016, there were 444 opioid-related overdose deaths: 98 involved synthetic opioids, 53 involved heroin, and 322 involved prescription opioids. Categories are not mutually exclusive because deaths may involve more than one drug.

Neonatal Abstinence Syndrome (NAS)

A CDC study analyzing 2013 NAS data available across 28 states estimated the national average NAS rate at 0.6 percent of live births (CDC, MMWR, 2014). Data for NAS rates in Oklahoma are unavailable.

HIV Prevalence and HIV Diagnoses Attributed to Injection Drug Use (IDU)

  • U.S. Incidence: In 2015, 9.1 percent (3,5941) of the 39,513 new diagnoses of HIV in the United States were attributed to IDU. Among new cases, 8.2 percent (2,6141) of cases among men and 13.2 percent (980) of cases among women were transmitted via IDU (CDC).
  • U.S. Prevalence: In 2014, 955,081 Americans were living with a diagnosed HIV infection—a rate of 299.5 per 100,000 persons. Of these, 18.1 percent (131,0561) of males and 22.6 percent (52,013) of females were living with HIV attributed to IDU (CDC).
  • State Incidence: Of the new HIV cases in 2015, 319 occurred in Oklahoma, with 15.9 percent1 of new cases in males and 17.5 percent of new cases in females attributed to IDU (AIDSVu).
  • State Prevalence: In 2014, an estimated 5,605 persons were living with a diagnosed HIV infection in Oklahoma—a rate of 176 infections per 100,000 persons. Of these, 19.4 percent1 of males and 28.0 percent of females were living with HIV attributed to IDU (AIDSVu).

Hepatitis C (HCV) Prevalence and HCV Diagnoses Attributed to Injection Drug Use

  • U.S. Incidence: In 2015, there were 181,871 reported cases of chronic HCV and 33,900 estimated cases of acute HCV2 (CDC). Where data were available, 64.2 percent of acute cases reported IDU (CDC).
  • U.S. Prevalence: An estimated 3.5 million Americans are living with HCV, including approximately 2.7 million living with chronic infections (CDC).
  • State Incidence: In 2015, Oklahoma reported 590 cases of chronic HCV (CDC) and 92 cases of acute HCV (2.4 cases per 100,000 persons) (OK.gov). Of these, 62.5 percent reported IDU (OK.gov).
  • State Prevalence: Current state prevalence data are not available. As of 2010, an estimated 94,200 persons (3,340 cases per 100,000) were living with HCV in Oklahoma (HepVu).

Additional Resources

NIH RePORTER FY2017 NIH-funded projects related to opioid use and use disorder in Oklahoma: 0

Notes

  1. Includes transmission to individuals with injection drug use as a risk factor.
  2. 2015 estimate after adjusting for under-ascertainment and under-reporting. Data for 2015 were unavailable for Alaska, Arizona, Connecticut, the District of Columbia, Hawaii, Iowa, Mississippi, New Hampshire, Rhode Island, and Wyoming.

This page was last updated February 2018

Get this Publication

Opioid Summaries by State

NIH HEAL (Helping to End Addiction Long-term) Initiative

New Opioid Overdose Materials for Patients

Easy-to-read Drug Facts

This Is NIDA: Opioids

This Is NIDA: Opioids

The National Institute on Drug Abuse's research-based, informative video series "This Is NIDA," addresses the topic of OPIOIDS.